GSK plc
GSK
#203
Rank
NZ$173.15 B
Marketcap
NZ$85.68
Share price
1.86%
Change (1 day)
41.20%
Change (1 year)

EPS for GSK plc (GSK)

EPS in 2025 (TTM): NZ$6.17

According to GSK plc's latest financial reports the company's current EPS (TTM) is NZ$5.97. In 2024 the company made an earnings per share (EPS) of NZ$2.65 a decrease over its 2023 EPS that were of NZ$5.03.

EPS history for GSK plc from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$6.17133.24%
2024NZ$2.65-47.35%
2023NZ$5.03-64.2%
2022NZ$14.04182.29%
2021NZ$4.98-18.07%
2020NZ$6.0722.34%
2019NZ$4.9623.9%
2018NZ$4.01140.61%
2017NZ$1.6764.45%
2016NZ$1.01-90.61%
2015NZ$10.78178.12%
2014NZ$3.88-48.11%
2013NZ$7.4722.68%
2012NZ$6.09-11.31%
2011NZ$6.86

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$12.22 104.68%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.86-52.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$6.15 3.05%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$12.61 111.18%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$5.04-15.60%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$1.05-82.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
NZ-$0.53-108.90%๐Ÿ‡บ๐Ÿ‡ธ USA